BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
PDX1
,
T cell receptor signaling pathway
,
Lung cancer
,
Kidney
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
negative regulation of glial cell proliferation
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Ovary
Mammary gland
Oral mucosa
Breast tissue
Peritoneum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Pain
1p partial monosomy syndrome
Age AND/OR growth finding
Poisoning by drug AND/OR medicinal substance
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Glesatinib
CGP 60474
ponatinib
ALW-II-49-7
GSK-1059615
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CTSL1
DROSHA
ANKRD2
PPP2R2C
PFAS
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
Embryonic stem cells differentiated in presence or absence of LIF
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for negative regulation of glial cell proliferation
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Utility of Primary Glioblastoma Cell Lines
A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cra…
CRF vs WCRF or PRF-DRG in CLBP of FJ Origin and RFA Failure of MBDR: Central Sensitization and Aberr…
Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer
Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ